首页> 外国专利> PREDICTION OF THE SUSCEPTIBILITY OF AN AT RISK PATIENT FOR DEVELOPING OR REDEVELOPING CLOSTRIDIUM DIFFICILE INFECTION

PREDICTION OF THE SUSCEPTIBILITY OF AN AT RISK PATIENT FOR DEVELOPING OR REDEVELOPING CLOSTRIDIUM DIFFICILE INFECTION

机译:预测发展或再发展艰难梭菌感染的高危患者的敏感性

摘要

A method for prediction of the susceptibility of an at risk patient to developing or redeveloping an infection with Clostridium difficile, having the determination by immunoassay, in a stool sample from said patient, of the level of antibody IgA anti-toxin B of Clostridium difficile, and comparing this level with a reference value S determined beforehand using two populations of patients exposed to the bacterium, one population not having developed or redeveloped such an infection and the other population having developed or redeveloped such an infection, —a level lower than said reference value S signifying that the patient is a patient with a heightened risk of developing or redeveloping a Clostridium difficile infection, and —a level higher than said reference value S signifying that the patient is not a patient with a heightened risk of developing or redeveloping a Clostridium difficile infection.
机译:一种用于预测高危患者对艰难梭状芽胞杆菌感染的敏感性的方法,该方法可通过免疫分析在该患者的粪便样本中测定抗IgA抗体的水平-I艰难梭菌毒素B,并将此水平与使用两个接触该细菌的患者群体预先确定的参考值S进行比较,一个群体未发生或再发展出这种感染,另一群体发生或重新发展了这种感染,-低于所述参考值S的水平表示患者是患有艰难梭状芽胞杆菌感染的高风险患者,并且-高于所述水平参考值S表示患者不是发展或再发展艰难梭菌感染的风险高的患者。

著录项

  • 公开/公告号US2017242006A1

    专利类型

  • 公开/公告日2017-08-24

    原文格式PDF

  • 申请/专利权人 BIOMERIEUX;

    申请/专利号US201515519724

  • 发明设计人 AGNÈS FOUSSADIER;MARK MILLER;

    申请日2015-10-16

  • 分类号G01N33/569;

  • 国家 US

  • 入库时间 2022-08-21 13:50:42

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号